- Home
- NRSN vs VRAR Comparison
NRSN vs VRAR Comparison
Compare NRSN & VRAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRSN
- VRAR
- Stock Information
- Founded
- NRSN 2017
- VRAR 2016
- Country
- NRSN Israel
- VRAR United States
- Employees
- NRSN N/A
- VRAR N/A
- Industry
- NRSN Biotechnology: Pharmaceutical Preparations
- VRAR Retail: Computer Software & Peripheral Equipment
- Sector
- NRSN Health Care
- VRAR Technology
- Exchange
- NRSN Nasdaq
- VRAR Nasdaq
- Market Cap
- NRSN 26.0M
- VRAR 26.9M
- IPO Year
- NRSN 2021
- VRAR 2021
- Fundamental
- Price
- NRSN $0.91
- VRAR $1.20
- Analyst Decision
- NRSN Hold
- VRAR Strong Buy
- Analyst Count
- NRSN 1
- VRAR 1
- Target Price
- NRSN N/A
- VRAR $4.67
- AVG Volume (30 Days)
- NRSN 172.3K
- VRAR 154.7K
- Earning Date
- NRSN 04-08-2025
- VRAR 05-14-2025
- Dividend Yield
- NRSN N/A
- VRAR N/A
- EPS Growth
- NRSN N/A
- VRAR N/A
- EPS
- NRSN N/A
- VRAR N/A
- Revenue
- NRSN N/A
- VRAR $9,230,197.00
- Revenue This Year
- NRSN N/A
- VRAR $39.02
- Revenue Next Year
- NRSN N/A
- VRAR N/A
- P/E Ratio
- NRSN N/A
- VRAR N/A
- Revenue Growth
- NRSN N/A
- VRAR N/A
- 52 Week Low
- NRSN $0.51
- VRAR $0.50
- 52 Week High
- NRSN $2.25
- VRAR $7.00
- Technical
- Relative Strength Index (RSI)
- NRSN 38.31
- VRAR 37.50
- Support Level
- NRSN $1.00
- VRAR $1.10
- Resistance Level
- NRSN $1.13
- VRAR $1.33
- Average True Range (ATR)
- NRSN 0.08
- VRAR 0.11
- MACD
- NRSN -0.02
- VRAR 0.01
- Stochastic Oscillator
- NRSN 28.23
- VRAR 5.88
About NRSN NeuroSense Therapeutics Ltd.
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, these diseases include Amyotrophic Lateral Sclerosis, or ALS, Alzheimer's disease and Parkinson's disease, among others. Its product candidate, PrimeC, is a novel extended-release, or ER, oral formulation of a fixed dose combination of two generic FDA-approved drugs, ciprofloxacin and celecoxib, combined in a specific ratio.
About VRAR The Glimpse Group Inc.
The Glimpse Group Inc is a diversified Virtual and Augmented Reality platform company, comprised of multiple VR and AR software and services companies, and designed with the specific purpose of cultivating companies in the emerging VR/AR industry.